HDAC9 and cancer: Epigenetic priming is perhaps even more likely to improve responses in a radiotherapy context given that HDAC inhibitors [75], decitabine [76], and RRx-001 [77], in particular, all induce oxidative stress, which, in turn, sensitizes cancer cells to the effects of ionizing radiation [78].